Megafine Pharma P Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Megafine Pharma is engaged in the production of APIs, and advanced intermediates, and offers contract manufacturing services.
One of their notable products is VENLAFAXINE HYDROCHLORIDE USP, with a corresponding US DMF Number 23102.
Remarkably, this DMF maintains an Active status since its submission on September 04, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 04, 2015, and payment made on April 09, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II